Skinvisible (SKVI) EBIAT (2016 - 2025)
Skinvisible (SKVI) has disclosed EBIAT for 16 consecutive years, with -$258357.0 as the latest value for Q4 2025.
- Quarterly EBIAT rose 99.37% to -$258357.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.1 million through Dec 2025, up 97.46% year-over-year, with the annual reading at -$1.1 million for FY2025, 88.11% down from the prior year.
- EBIAT hit -$258357.0 in Q4 2025 for Skinvisible, down from -$250245.0 in the prior quarter.
- In the past five years, EBIAT ranged from a high of -$191723.0 in Q2 2022 to a low of -$41.0 million in Q4 2024.
- Historically, EBIAT has averaged -$8.1 million across 5 years, with a median of -$287061.0 in 2023.
- Biggest five-year swings in EBIAT: crashed 606.26% in 2023 and later surged 99.37% in 2025.
- Year by year, EBIAT stood at -$35.8 million in 2021, then fell by 10.08% to -$39.4 million in 2022, then dropped by 2.85% to -$40.5 million in 2023, then decreased by 1.26% to -$41.0 million in 2024, then soared by 99.37% to -$258357.0 in 2025.
- Business Quant data shows EBIAT for SKVI at -$258357.0 in Q4 2025, -$250245.0 in Q3 2025, and -$274427.0 in Q2 2025.